Resultados de la búsqueda 11-20 of 2620 for Inhibition
... inhibitor. In the phase II part, to evaluate the preliminary antitumor activity of two different doses/regimens of [177Lu]Lu-NeoB in combination with ...
PARP inhibitors block the action of enzymes in the cancer cells that help repair breaks in the DNA. These targeted therapy medicines work best in people with ...
The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L) ...
... inhibitors sirolimus or everolimus as part of their clinical care. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now.
... inhibitor). Cell Saver During Tumor Resection. Rochester, Minn. The aims of this study are to investigate the presence of tumor cells after filtration of ...
Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis ... To evaluate the incidence of immune checkpoint inhibitors (ICI)-induced colitis (IIC) ...
... inhibitors treatments, have been unsuccessful or not well tolerated, and the patient has a GFR ≥ 45 ml/min/1.73m2, or the patient is post renal transplantation ...
Therefore, we propose to examine urinary protein crystallization inhibitors in patient populations that have been carefully phenotyped relative to renal stone ...
... inhibition. We hypothesize that targeting melanoma with a PD-1 (MC9324) CAR TIL therapy would capitalize on the tumor homing machinery of the TIL to drive ...
... inhibitor). Genomic and Proteomic Analyses of Aggressive Tumors. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?